Retrospective reimbursement prices for January, August and October 2025
Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has redetermined January, August and October 2025 reimbursement prices for the following products to reflect an increase in their NHS list prices.
To avoid pharmacy owners dispensing these products at a loss, DHSC has agreed to grant retrospective price adjustments for the following products prescribed by brand or generically. These interventions by our Dispensing and Supply Team have prevented community pharmacies from losing an estimated £58k to medicine price rises.
October 2025 price adjustments
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price | Drug Tariff Category |
| Generic Maxijul Super Soluble powder | Maxijul® Super Soluble powder (Nutricia Ltd) | 25000 grams | £234.85 | £ 244.47 | Non Drug Tariff |
| Generic Phlexy-Vits powder 7g sachets | Phlexy-Vits® powder 7g sachets (Nutricia Ltd) | 30 sachet | £103.50 | £107.70 | Non Drug Tariff |
| Generic Phlexy-Vits tablets | Phlexy-Vits® tablets (Nutricia Ltd) | 180 tablets | £119.35 | £124.24 | Non Drug Tariff |
| Generic PKU Anamix Junior powder 36g sachets | PKU Anamix Junior® powder 36g sachets neutral (Nutricia Ltd) | 30 sachets | £184.20 | £191.70 | Non Drug Tariff |
| Generic Complete Amino Acid Mix powder | Complete Amino Acid® Mix powder (Nutricia Ltd) | 200 grams | £137.30 | £142.93 | Non Drug Tariff |
August 2025 price adjustments
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price | Drug Tariff Category |
|
Colistimethate 1million unit powder for solution for injection vials
|
Colomycin® 1million unit powder for solution for injection vials (Teva UK Ltd) | 10 vials | £18.00 | £33.98 | Part VIIIA Category C |
| Colistimethate 2million unit powder for solution for injection vials | Colomycin® 2million unit powder for solution for injection vials (Teva UK Ltd) | 10 vials | £32.40 | £54.96 | Part VIIIA Category C |
January 2025 price adjustments
| Generic name | Brand name | Pack size | Previous NHS list price | Redetermined reimbursement price | Drug Tariff Category |
|
Acetylcysteine 5% eye drops
|
Ilube® 5% eye drops (Rayner Pharmaceuticals Ltd) | 10mls | £80.95 | £92.75 | Part VIIIA Category C |
Under the current price change mechanism, pharmacy owners would have to wait one (or in some cases two months) before any NHS list prices changes are applied to reimbursement of branded products. The delays in reimbursement prices catching up with any NHS list price increases can lead to dispensing at a loss, as pharmacies will be reimbursed based on the previous NHS list price until the price change is adjusted in line with the price change timetable. The impact is more significant for products with large list price increases or for high volume lines. To avoid pharmacy owners dispensing these products at a loss, Community Pharmacy England requested DHSC to redetermine the reimbursement prices for the products listed above.
Community Pharmacy England is awaiting confirmation from DHSC as to when pharmacy owners can expect to receive their adjusted payments for the specified items. The payments will appear as ‘Adjustment drugs‘ and ‘Adjustment fees’ (if applicable). The adjustments for products listed above will be shown as a combined total.
Community Pharmacy England sought price adjustments to several other products affected by NHS list price increases in August 2025. However, DHSC took the decision not to grant price redeterminations for all the products requested. Community Pharmacy England continues to seek a review of the current price change timetable for branded products so that there is no extra months’ delay in applying any new list prices changes to reimbursement.
